75 related articles for article (PubMed ID: 27071615)
1. IL-6 induced proliferation and cytotoxic activity of CD8(+) T cells is elevated by SUMO2 overexpression.
Lee YJ; Won TJ; Hyung KE; Jang YW; Kim SJ; Lee do I; Park SY; Hwang KW
Arch Pharm Res; 2016 May; 39(5):705-12. PubMed ID: 27071615
[TBL] [Abstract][Full Text] [Related]
2. SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8⁺ T cells in mice.
Won TJ; Lee YJ; Hyung KE; Yang E; Sohn UD; Min HY; Lee DI; Park SY; Hwang KW
Cell Signal; 2015 Jun; 27(6):1246-52. PubMed ID: 25762490
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.
Ramanathan S; Dubois S; Gagnon J; Leblanc C; Mariathasan S; Ferbeyre G; Rottapel R; Ohashi PS; Ilangumaran S
J Immunol; 2010 Jul; 185(1):357-66. PubMed ID: 20519645
[TBL] [Abstract][Full Text] [Related]
4. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
5. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the regulatory roles of the SUMO.
Hwang KW; Won TJ; Kim H; Chun HJ; Chun T; Park Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):854-61. PubMed ID: 22069273
[TBL] [Abstract][Full Text] [Related]
7. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
8. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
[TBL] [Abstract][Full Text] [Related]
9. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
10. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
11. The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation.
Peperzak V; Veraar EA; Keller AM; Xiao Y; Borst J
J Immunol; 2010 Dec; 185(11):6670-8. PubMed ID: 21048108
[TBL] [Abstract][Full Text] [Related]
12. Unique features of naive CD8+ T cell activation by IL-2.
Cho JH; Kim HO; Kim KS; Yang DH; Surh CD; Sprent J
J Immunol; 2013 Dec; 191(11):5559-73. PubMed ID: 24166977
[TBL] [Abstract][Full Text] [Related]
13. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
14. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
Liu SJ; Tsai JP; Shen CR; Sher YP; Hsieh CL; Yeh YC; Chou AH; Chang SR; Hsiao KN; Yu FW; Chen HW
J Leukoc Biol; 2007 Aug; 82(2):354-60. PubMed ID: 17505023
[TBL] [Abstract][Full Text] [Related]
15. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
[TBL] [Abstract][Full Text] [Related]
16. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
17. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
Ramanathan S; Dubois S; Chen XL; Leblanc C; Ohashi PS; Ilangumaran S
J Immunol; 2011 May; 186(9):5131-41. PubMed ID: 21430227
[TBL] [Abstract][Full Text] [Related]
18. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice.
Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M
Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression.
Yang W; Paschen W
Biochem Biophys Res Commun; 2009 Apr; 382(1):215-8. PubMed ID: 19275883
[TBL] [Abstract][Full Text] [Related]
20. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
